Björnsson E, Schröder R, Nielsen H. "一种艾氟康唑杂质51的合成方法" [P]. European Patent, EP 3400757 A1, 2025-06-05.
发明人马晓峰,郑宇鹏,朱建伟. "Method for the Synthesis of Efinaconazole impurity 51" [P]. 中国发明专利, 专利号 CN 108974573 B, 授权公告日 2024-08-14.
发明人郭海燕,韩伟,何建平. "A Process for Preparing High-Purity Efinaconazole impurity 51" [P]. 中国发明专利, 专利号 CN 115370228 A, 授权公告日 2022-04-25.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 艾氟康唑杂质51 in Pharmaceutical Formulations". Phytochemistry, 2018, 2328, (8), 4773-4778.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 艾氟康唑杂质51 as an Impurity". J. Pharm. Biomed. Anal., 2020, 2087, 9288-9312.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Efinaconazole impurity 51 Using HRMS and NMR". Molecules, 2010, 1179, 8609-8612.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 艾氟康唑杂质51 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2019, 250, 3756-3775.